Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Furer

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
The Journal of Rheumatology|November 1, 2023
Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent ControlsTali Eviatar, Victoria Furer, Ari Polachek, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 20, 2022
The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patientsEsther Saiag, Ayelet Grupper, Irit Avivi, et al.
Rheumatology (Oxford, England)|March 18, 2021
Ultrasound, magnetic resonance imaging and radiography of the finger joints in psoriatic arthritis patientsAri Polachek, Victoria Furer, Mirna Zureik, et al.
Annals of the Rheumatic Diseases|July 22, 2022
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre studyVictoria Furer, Tali Eviatar, Tal Freund, et al.
Science Immunology|June 6, 2025
Dissection of the immune landscape in psoriatic arthritis defines immunoproteasome up-regulation in treatment resistanceReut Tzemach, Chamutal Gur, Truong San Phan, et al.
Vaccines|June 24, 2022
Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with RituximabVictoria Furer, Tali Eviatar, Devy Zisman, et al.
Annals of the Rheumatic Diseases|July 3, 2021
Role of ultrasound for assessment of psoriatic arthritis patients with fibromyalgiaAri Polachek, Victoria Furer, Mirna Zureik, et al.
Clinical and Experimental Rheumatology|May 19, 2026
Semen analysis of patients with psoriatic arthritis, axial spondyloarthritis and healthy controlsKatya Meridor, Shimi Barda, Ofir Elalouf, et al.
Seminars in Arthritis and Rheumatism|February 21, 2026
Evolution of Janus Kinase inhibitors (JAKi) prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study): effect of regulatory warningsDenis Mongin, Romain Aymon, Denis Choquette, et al.
RMD Open|October 1, 2019
Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendationsChristien Rondaan, Victoria Furer, Marloes W Heijstek, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
The Journal of Rheumatology|November 1, 2023
Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent ControlsTali Eviatar, Victoria Furer, Ari Polachek, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 20, 2022
The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patientsEsther Saiag, Ayelet Grupper, Irit Avivi, et al.
Rheumatology (Oxford, England)|March 18, 2021
Ultrasound, magnetic resonance imaging and radiography of the finger joints in psoriatic arthritis patientsAri Polachek, Victoria Furer, Mirna Zureik, et al.
Annals of the Rheumatic Diseases|July 22, 2022
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre studyVictoria Furer, Tali Eviatar, Tal Freund, et al.
Science Immunology|June 6, 2025
Dissection of the immune landscape in psoriatic arthritis defines immunoproteasome up-regulation in treatment resistanceReut Tzemach, Chamutal Gur, Truong San Phan, et al.
Vaccines|June 24, 2022
Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with RituximabVictoria Furer, Tali Eviatar, Devy Zisman, et al.
Annals of the Rheumatic Diseases|July 3, 2021
Role of ultrasound for assessment of psoriatic arthritis patients with fibromyalgiaAri Polachek, Victoria Furer, Mirna Zureik, et al.
Clinical and Experimental Rheumatology|May 19, 2026
Semen analysis of patients with psoriatic arthritis, axial spondyloarthritis and healthy controlsKatya Meridor, Shimi Barda, Ofir Elalouf, et al.
Seminars in Arthritis and Rheumatism|February 21, 2026
Evolution of Janus Kinase inhibitors (JAKi) prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study): effect of regulatory warningsDenis Mongin, Romain Aymon, Denis Choquette, et al.
RMD Open|October 1, 2019
Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendationsChristien Rondaan, Victoria Furer, Marloes W Heijstek, et al.
Pageof 8